Human Chorionic Gonadotropin 10000iu (Generic)

Product Overview

Human Chorionic Gonadotropin 10000iu (Generic) is a clinically formulated injectable solution intended for the management of female infertility. Each package contains a single 1 mL vial delivering a potent 10,000 International Units of recombinant HCG, sealed under sterile conditions by German Remedies Private Ltd. The product is supplied in a compact box, making it convenient for pharmacy dispensing and patient administration. Indicated specifically for ovulation induction and support of luteal phase function, this generic formulation offers a cost‑effective alternative to branded gonadotropins while maintaining the same pharmacological profile. Storage requires refrigeration between 2 °C and 8 °C, and the vial should be gently swirled—not shaken—before use to preserve biological activity.

What is Human Chorionic Gonadotropin 10000iu (Generic)

Human Chorionic Gonadotropin, commonly abbreviated HCG, is a glycoprotein hormone produced by the syncytiotrophoblast of the placenta. In clinical practice, recombinant HCG mimics the endogenous hormone that stimulates the luteinizing hormone (LH) receptors on ovarian granulosa cells, thereby triggering the final maturation and release of a mature oocyte. The generic version contains the identical amino‑acid sequence as the reference product, is manufactured under Good Manufacturing Practice (GMP) standards, and undergoes rigorous purification to ensure consistency and potency. Because it is chemically indistinguishable from the branded counterpart, clinicians can confidently prescribe it for assisted reproductive technologies, including in‑vitro fertilisation (IVF) and controlled ovarian hyperstimulation.

Uses and Benefits

The primary therapeutic use of Human Chorionic Gonadotropin 10000iu is to induce final follicular maturation and ovulation in women undergoing fertility treatment. When administered at the appropriate phase of the menstrual cycle, HCG prompts the ruptured follicle to release an oocyte, which can then be fertilised in the laboratory or within the fallopian tube. Additional benefits include support for the luteal phase, improving implantation rates, and providing a predictable ovulation trigger that reduces the need for frequent ultrasound monitoring. For patients with polycystic ovary syndrome (PCOS) or unexplained infertility, HCG offers a targeted approach that can be combined with other ovulation agents such as clomiphene citrate or letrozole. Real‑world studies have demonstrated live‑birth rates comparable to those achieved with more expensive brand‑name gonadotropins when used according to established protocols.

How It Works

Upon subcutaneous or intramuscular injection, the recombinant HCG binds to LH receptors on the ovarian granulosa cells, activating intracellular cyclic AMP pathways that drive the production of intracellular steroids and finalize follicular development. This biochemical cascade culminates in the rupture of the dominant follicle and the release of a mature oocyte, a process that typically occurs within 36 hours after administration. The hormone also exerts ancillary effects on the corpus luteum, promoting progesterone synthesis that prepares the endometrium for potential embryo implantation. For a deeper scientific overview, reputable sources such as the National Institutes of Health (NIH) provide comprehensive explanations of HCG physiology and its therapeutic applications; you can explore the NIH’s HCG page here.

Dosage Guidelines

Dosage of Human Chorionic Gonadotropin 10000iu must always be individualized by a qualified reproductive endocrinologist. In most clinical protocols, a single dose of 10,000 IU is administered to trigger ovulation once the leading follicle reaches a mean diameter of 18–20 mm on transvaginal ultrasound. Some protocols may incorporate a trigger dose of 5,000–10,000 IU depending on the stimulation regimen and patient response. The medication is supplied as a lyophilized powder that must be reconstituted with the accompanying solvent before injection. Patients should be instructed to rotate injection sites, maintain aseptic technique, and report any adverse reactions promptly. Comprehensive dosing information is available in the official FDA prescribing information; for reference, see the FDA label here.

Side Effects

Like all hormonal medications, Human Chorionic Gonadotropin 10000iu can be associated with side effects, most of which are mild and self‑limiting. Commonly reported adverse events include headache, nausea, abdominal discomfort, and transient injection‑site reactions such as redness or bruising. Less frequently, patients may experience ovarian hyperstimulation syndrome (OHSS), characterized by rapid weight gain, abdominal distension, and shortness of breath; in such cases, medical attention should be sought immediately. Rarely, allergic reactions ranging from mild rash to anaphylaxis have been documented. For an authoritative list of side effects, clinicians and patients can consult the MedlinePlus database, which provides patient‑friendly safety information here.

Warnings and Precautions

This medication is contraindicated in individuals with known hypersensitivity to HCG or any of the formulation excipients. It should not be used in patients with active ovarian cysts unrelated to fertility treatment, or in those with a history of thrombotic disorders without appropriate evaluation. Caution is advised in women with uncontrolled thyroid disease, severe pelvic infections, or suspected ectopic pregnancy. Prior to administration, a thorough medical history and baseline laboratory testing—including serum beta‑hCG levels—are recommended to ensure safety. Pregnant women must avoid use, as exogenous HCG may interfere with diagnostic testing and fetal development. Full prescribing information and safety considerations are detailed on Drugs.com, a reliable source for drug warnings here.

Frequently Asked Questions

Q1: What distinguishes the generic HCG from the branded version? A1: The generic formulation contains the same recombinant protein, identical amino‑acid sequence, and equivalent potency, but is produced at a lower cost, making it more accessible while meeting the same regulatory standards.

Q2: How should the vial be stored before use? A2: The vial must be refrigerated at 2 °C to 8 °C and protected from light; once reconstituted, the solution can be kept at room temperature for up to 24 hours if used promptly.

Q3: Can HCG be self‑administered at home? A3: Yes, after proper training and under physician guidance, patients may self‑inject subcutaneously; however, the first dose should always be overseen by a healthcare professional to confirm technique and tolerance.

Q4: Is HCG safe for women with polycystic ovary syndrome? A4: In carefully monitored cycles, HCG is considered safe for PCOS patients, but clinicians must adjust dosing to minimise the risk of OHSS, which is more prevalent in this population.

Q5: Where can I find more detailed prescribing information? A5: Detailed dosing, contraindications, and adverse‑event reporting are available in the FDA’s official prescribing information and on reputable pharmacy‑counseling sites such as Drugs.com.